Resources from the same session
ATHENA (GOG-3020/ENGOT-ov45): A randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Presenter: Rebecca Kristeleit
Session: Clinical trial highlights
Resources:
Slides
Webcast
Invited Discussant of PRIME and ATHENA-MONO studies
Presenter: Mansoor Raza Mirza
Session: Clinical trial highlights
Resources:
Slides
Webcast
Live Q&A
Presenter: Susana Banerjee
Session: Clinical trial highlights
Resources:
Webcast
SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer
Presenter: Vicky Makker
Session: Clinical trial highlights
Resources:
Webcast
MITO 23: A randomized phase III trial on trabectedin vs physician choice chemotherapy in BRCA mut and BRCAness ovarian cancer
Presenter: Domenica Lorusso
Session: Clinical trial highlights
Resources:
Slides
Webcast
Invited Discussant of SIENDO/ENGOT-EN5 and MITO 23 studies
Presenter: Isabelle Ray-Coquard
Session: Clinical trial highlights
Resources:
Slides
Webcast
Live Q&A
Presenter: Susana Banerjee
Session: Clinical trial highlights
Resources:
Webcast